Evonik completes acquisition of Tippecanoe Laboratories in USA
08-Jan-2010
- USA
The site has a workforce of some 650 and produces active ingredients and intermediates for the pharmaceuticals industry. The deal includes a long-term partnership with Lilly for the production of active ingredients and a multi-year supply agreement for active ingredients and intermediates for pharmaceuticals. The site will be fully integrated into Evonik’s global production and marketing network.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.